Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
15254 participants
OBSERVATIONAL
2016-08-04
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types
NCT03085888
Study of Tissue and Blood Samples From Patients With High-Grade Glioma
NCT01004887
PATHFINDER 2: a Multi-Cancer Early Detection Study
NCT05155605
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
NCT05366881
Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
NCT01004523
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cancer arm
Participants with new diagnosis of cancer (multiple tumor types) from which a blood sample and contemporaneous FFPE tumor tissue will be collected.
No interventions assigned to this group
Non-cancer arm
Participants with no known diagnosis or past history of cancer from which a blood sample will be collected.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide a written informed consent
* Age 20 years or older
* Able to provide a written informed consent
Have either of the following:
A. Confirmed cancer diagnosis (any stage I-IV, as well as carcinoma in situ (CIS) within 90 days prior to or up to 42 days after study blood draw, based upon assessment of a pathological specimen
OR
B. A high suspicion for a cancer diagnosis by clinical and/or radiological assessment, with planned biopsy or surgical resection to establish a definitive diagnosis within 6 weeks (42 days) after study blood draw
Exclusion Criteria
* Oral or IV corticosteroid use in past 14 days prior to blood draw
* Pregnancy (by self-report)
* Current febrile illness
* Acute exacerbation or flare of an inflammatory condition requiring escalation in medical therapy within 14 days prior to blood draw.
* Recipient of organ transplant or prior non-autologous (allogeneic) bone marrow or stem cell transplant
* Poor health status or unfit to tolerate blood draw
* Known prior diagnosis of cancer except non-melanoma skin cancer
* Currently receiving, or ever received, any of the following therapies to treat their current cancer: surgical management of the cancer beyond that required to establish the cancer diagnosis; local, regional or systemic chemotherapy including chemoembolization; targeted therapy, immunotherapy including cancer vaccines; hormone therapy; or radiation therapy
* Pregnancy (by self-report)
* Current febrile illness
* Acute exacerbation or flare of an inflammatory condition requiring escalation in medical therapy within 14 days prior to blood draw.
* Recipient of organ transplant or prior non-autologous (allogeneic) bone marrow or stem cell transplant
* Poor health status or unfit to tolerate blood draw
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GRAIL, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Fung, MD, PhD
Role: STUDY_DIRECTOR
GRAIL, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southern Cancer Center, PC - Daphne
Daphne, Alabama, United States
Southern Cancer Center, P.C. - Mobile Infirmary
Mobile, Alabama, United States
Southern Cancer Center, PC - Mobile Airport
Mobile, Alabama, United States
Southern Cancer Center, PC - Springhill Medical Center
Mobile, Alabama, United States
Mayo Clinic - Arizona
Phoenix, Arizona, United States
Mercy Fort Smith
Fort Smith, Arkansas, United States
Sansum Clinic - 540
Santa Barbara, California, United States
Sansum Clinic- 317
Santa Barbara, California, United States
Sansum Clinic - Viborg
Solvang, California, United States
Rocky Mountain Cancer Centers
Aurora, Colorado, United States
Rocky Mountain Cancer Center
Boulder, Colorado, United States
Rocky Mountain Cancer Centers
Centennial, Colorado, United States
Rocky Mountain Cancer Center
Colorado Springs, Colorado, United States
Rocky Mountain Cancer Centers
Denver, Colorado, United States
Rocky Mountain Cancer Centers
Denver, Colorado, United States
Rocky Mountain Cancer Centers
Englewood, Colorado, United States
Rocky Mountain Cancer Center
Lakewood, Colorado, United States
Rocky Mountain Cancer Centers
Littleton, Colorado, United States
Rocky Mountain Cancer Centers
Lone Tree, Colorado, United States
Rocky Mountain Cancer Centers
Longmont, Colorado, United States
Rocky Mountain Cancer Center
Pueblo, Colorado, United States
Rocky Mountain Cancer Centers
Thornton, Colorado, United States
Hartford HealthCare Cancer Institute at Hartford Hospital
Hartford, Connecticut, United States
Hartford New Britain
New Britain, Connecticut, United States
UMHC Lennar Foundation - Coral Gables
Coral Gables, Florida, United States
UMHC Sylvester- Coral Springs
Coral Springs, Florida, United States
University of Miami Sylvester at Deerfield Beach
Deerfield Beach, Florida, United States
University of Miami Sylvester at Hollywood
Hollywood, Florida, United States
Mayo Clinic - Florida
Jacksonville, Florida, United States
University of Miami Sylvester at Kendall
Kendall, Florida, United States
University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, United States
Florida Cancer Affiliates - Ocala
Ocala, Florida, United States
Woodlands Medical Specialists, PA
Pensacola, Florida, United States
University of Miami Sylvester at Plantation
Plantation, Florida, United States
Illinois Cancer Specialists
Arlington Heights, Illinois, United States
Illinois Cancer Specialists
Niles, Illinois, United States
Baptist Health Lexington
Lexington, Kentucky, United States
Baptist Health Louisville
Louisville, Kentucky, United States
Baptist Health Paducah
Paducah, Kentucky, United States
Maryland Oncology Hematology, P.A.
Bethesda, Maryland, United States
Maryland Oncology Hematology, P.A.
Brandywine, Maryland, United States
Maryland Oncology Hematology, P.A.
Clinton, Maryland, United States
Maryland Oncology Hematology, P.A.
Columbia, Maryland, United States
Maryland Oncology Hematology, P.A.
Rockville, Maryland, United States
Maryland Oncology Hematology, P.A.
Silver Spring, Maryland, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Lahey Hospital & Medical Center
Burlington, Massachusetts, United States
Lahey Hospital & Medical Center - Peabody
Peabody, Massachusetts, United States
Minnesota Oncology Hematology, P.A. - Main
Coon Rapids, Minnesota, United States
Minnesota Oncology Hematology, P.A. - Edina
Edina, Minnesota, United States
Minnesota Oncology Hematology, P.A. - Woodbury
Minneapolis, Minnesota, United States
Mayo Clinic - Rochester
Rochester, Minnesota, United States
Minnesota Oncology Hematology, P.A. - Coon Rapids
Woodbury, Minnesota, United States
Mercy Joplin
Joplin, Missouri, United States
Mercy Research - Springfield
Springfield, Missouri, United States
Memorial Sloan Kettering - Basking Ridge
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering, NY - Monmouth
Middletown, New Jersey, United States
New York Oncology Hematology, P.C.
Albany, New York, United States
New York Oncology Hematology, P.C.
Albany, New York, United States
Broome Oncology, LLC
Binghamton, New York, United States
New York Oncology Hematology, P.C.
Clifton Park, New York, United States
Broome Oncology, LLC
Johnson City, New York, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Memorial Sloan Kettering - Rockville Center
New York, New York, United States
Memorial Sloan Kettering, NY - Commack
New York, New York, United States
Memorial Sloan Kettering, NY - West Harrison
New York, New York, United States
Memorial Sloan Kettering
New York, New York, United States
Oncology Hematology Care, Inc. - Reading Road
Cincinnati, Ohio, United States
Oncology Hematology Care, Inc. - Fairfield
Cincinnati, Ohio, United States
Christ Hospital Health Network - The Lindner Center Cancer Research Division
Cincinnati, Ohio, United States
Oncology Hematology Care, Inc. - Mercy Health
Cincinnati, Ohio, United States
Oncology Hematology Care, Inc. - E. Galbraith
Cincinnati, Ohio, United States
Oncology Hematology Care, Inc. - Malsbary
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Oncology Hematology Care, Inc. - Five Mile Road
Fairfield, Ohio, United States
Oregon Health & Science University Knight Cancer Institute
Portland, Oregon, United States
Northwest Cancer Specialists, P.C. dba Compass Oncology
Portland, Oregon, United States
Northwest Cancer Specialists, P.C. dba Compass Oncology
Portland, Oregon, United States
Northwest Cancer Specialists, P.C. dba Compass Oncology
Portland, Oregon, United States
Northwest Cancer Specialists, P.C. dba Compass Oncology
Tualatin, Oregon, United States
Lehigh Valley Hospital - Cedar Crest
Allentown, Pennsylvania, United States
Cancer Center at Lehigh Valley Hospital - Muhlenberg
Bethlehem, Pennsylvania, United States
Bon Secours Saint Francis Cancer Center
Greenville, South Carolina, United States
Prisma Health - Upstate
Seneca, South Carolina, United States
Spartanburg Regional Healthcare System
Spartanburg, South Carolina, United States
Avera Research Institute
Sioux Falls, South Dakota, United States
Tennessee Oncology Medical Park II
Chattanooga, Tennessee, United States
Tennessee Oncology Memorial Plaza
Chattanooga, Tennessee, United States
Tennessee Oncology Cleveland Clinic
Cleveland, Tennessee, United States
Tennessee Oncology CMC
Crossville, Tennessee, United States
Tennessee Oncology Dickson
Dickson, Tennessee, United States
Tennessee Oncology Franklin
Franklin, Tennessee, United States
Tennessee Oncology Gallatin
Gallatin, Tennessee, United States
Tennessee Oncology Summit
Hermitage, Tennessee, United States
Tennessee Oncology Lebanon
Lebanon, Tennessee, United States
Tennessee Oncology Murfreesboro
Murfreesboro, Tennessee, United States
Tennessee Oncology Midtown
Nashville, Tennessee, United States
Tennessee Oncology Nashville
Nashville, Tennessee, United States
Tennessee Oncology SCCBC
Nashville, Tennessee, United States
Tennessee Oncology St. Thomas West
Nashville, Tennessee, United States
Tennessee Oncology Skyline
Nashville, Tennessee, United States
Tennessee Oncology Southern Hills
Nashville, Tennessee, United States
Tennessee Oncology Shelbyville
Shelbyville, Tennessee, United States
Tennessee Oncology Stonecrest
Smyrna, Tennessee, United States
Texas Oncology - West Texas
Amarillo, Texas, United States
Texas Oncology-Bedford
Bedford, Texas, United States
TXO - Methodist Dallas Cancer Center
Dallas, Texas, United States
Texas Oncology - Dallas Forest Ln
Dallas, Texas, United States
Texas Oncology - Presbyterian Cancer Center Dallas
Dallas, Texas, United States
Texas Oncology - Baylor Charles A. Sammons Cancer Center
Dallas, Texas, United States
Texas Oncology-Fort Worth
Fort Worth, Texas, United States
Texas Oncology-Southwest Fort Worth
Fort Worth, Texas, United States
Texas Oncology - Grapevine
Grapevine, Texas, United States
Texas Oncology Cancer Care and Research Center - Harlingen
Harlingen, Texas, United States
Texas Oncology - Longview Cancer Center
Longview, Texas, United States
Texas Oncology - McAllen
McAllen, Texas, United States
Texas Oncology - Mesquite
Mesquite, Texas, United States
Texas Oncology-New Braunfels
New Braunfels, Texas, United States
Texas Oncology - Plano East
Plano, Texas, United States
Texas Oncology - Plano West
Plano, Texas, United States
Texas Oncology - Rockwall
Rockwall, Texas, United States
Texas Oncology-San Antonio Downtown
San Antonio, Texas, United States
Texas Oncology - San Antonio Northeast
San Antonio, Texas, United States
Texas Oncology-San Antonio Medical Center
San Antonio, Texas, United States
Texas Oncology-San Antonio Stone Oak
San Antonio, Texas, United States
Texas Oncology - Sherman
Sherman, Texas, United States
Texas Oncology-The Woodlands
The Woodlands, Texas, United States
Texas Oncology - Tyler
Tyler, Texas, United States
Texas Oncology - Weslaco
Weslaco, Texas, United States
Texas Oncology - West Texas
Wichita Falls, Texas, United States
Virginia Cancer Specialists, PC
Alexandria, Virginia, United States
Virginia Cancer Specialists, PC
Arlington, Virginia, United States
Virginia Cancer Specialists, PC
Fairfax, Virginia, United States
Virginia Cancer Specialists, PC
Gainesville, Virginia, United States
Virginia Cancer Specialists, PC
Leesburg, Virginia, United States
Virginia Cancer Specialists, PC
Woodbridge, Virginia, United States
Benaroya Research Institute at Virginia Mason
Seattle, Washington, United States
Northwest Cancer Specialists, P.C. dba Compass Oncology
Vancouver, Washington, United States
Yakima Valley Memorial Hospital/North Star Lodge
Yakima, Washington, United States
UHN Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mahal BA, Margolis M, Hubbell E, Chen C, Venstrom JM, Abran J, Kartlitz JJ, Wyatt AW, Klein EA. A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease. JCO Precis Oncol. 2024 Aug;8:e2400269. doi: 10.1200/PO.24.00269.
Bryce AH, Thiel DD, Seiden MV, Richards D, Luan Y, Coignet M, Zhang Q, Zhang N, Hubbell E, Kurtzman KN, Klein EA. Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers. JCO Precis Oncol. 2023 Jul;7:e2200679. doi: 10.1200/PO.22.00679.
Tang WHW, Yimer H, Tummala M, Shao S, Chung G, Clement J, Chu BC, Hubbell E, Kurtzman KN, Swanton C, Roberts LR. Performance of a targeted methylation-based multi-cancer early detection test by race and ethnicity. Prev Med. 2023 Feb;167:107384. doi: 10.1016/j.ypmed.2022.107384. Epub 2022 Dec 7.
Shao SH, Allen B, Clement J, Chung G, Gao J, Hubbell E, Liu MC, Swanton C, Tang WHW, Yimer H, Tummala M. Multi-cancer early detection test sensitivity for cancers with and without current population-level screening options. Tumori. 2023 Jun;109(3):335-341. doi: 10.1177/03008916221133136. Epub 2022 Oct 31.
Bredno J, Lipson J, Venn O, Aravanis AM, Jamshidi A. Clinical correlates of circulating cell-free DNA tumor fraction. PLoS One. 2021 Aug 25;16(8):e0256436. doi: 10.1371/journal.pone.0256436. eCollection 2021.
Klein EA, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D, Chung G, Clement J, Gao J, Hunkapiller N, Jamshidi A, Kurtzman KN, Seiden MV, Swanton C, Liu MC. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021 Sep;32(9):1167-1177. doi: 10.1016/j.annonc.2021.05.806. Epub 2021 Jun 24.
Larson MH, Pan W, Kim HJ, Mauntz RE, Stuart SM, Pimentel M, Zhou Y, Knudsgaard P, Demas V, Aravanis AM, Jamshidi A. A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection. Nat Commun. 2021 Apr 21;12(1):2357. doi: 10.1038/s41467-021-22444-1.
Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV; CCGA Consortium. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020 Jun;31(6):745-759. doi: 10.1016/j.annonc.2020.02.011. Epub 2020 Mar 30.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRAIL-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.